Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9319 | 0.87 | — | — | |
| Methane SCHEMBL27677204 | 0.85 | — | — | |
| SCHEMBL27763265 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL27996106 | 0.85 | — | — | |
| Hydrogen Sulfide SCHEMBL29094904 | 0.85 | — | — | |
| Isonicotinic Acid SCHEMBL1705745 | 0.83 | NAPRT (0.49) | NAPRT | |
| Piperazine SCHEMBL28273581 | 0.78 | DRD2 (0.33) | DRD2DRD4DRD3MAOA | |
| Pyridine SCHEMBL28078338 | 0.77 | TSHR (0.38) | TSHRNAPRTTDP1DRD2DRD4 | |
| SCHEMBL28059230 | 0.76 | GABRA1 (0.35) | MAOA | |
| SCHEMBL1953605 | 0.76 | P2RX7 (0.39) | NAPRT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103827094-B | Hiv replication inhibitors | 南方研究所 | 2017-09-26 | — | — | CN | disclosed |
| CN-105307800-B | Metal nanoparticles | LG化学株式会社 | 2017-05-03 | — | — | CN | disclosed |
| CN-106103737-A | System and method for emulsion decomposition | 生命科技公司 | 2016-11-09 | — | — | CN | disclosed |